Business
Aclarion Adds High-Volume Practice, Source Healthcare, to Support Nociscan Growth and Real-World Evidence Generation
Expands availability of Nociscan in the greater Los Angeles areaReinforces Nociscan’s non-invasive advantage with real-world clinical validation compared to anesthetic discography, a spinal injection procedureSupports scalable growth strategy while building data assets critical to payer and provider adoption BROOMFIELD, Colo., Feb. 03, 2026 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a commercial-stage healthcare technology company that is leveraging
About this update from Aclarion, Inc.
[{"type":"image","alt":"Aclarion, Inc.","displaySize":"","headline":null,"caption":"Aclarion, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":140,"height":83,"url":"https://media.zenfs.com/en/globenewswire.com/ba6de721dd8ef6e3bce232e051476ebf"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/JqjNbxSKpdl2ksI_nXtiLg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIxMDtoPTEyNTtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/ba6de721dd8ef6e3bce232e051476ebf","width":140,"height":83}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"Expands availability of Nociscan in the greater Los Angeles area","length":64,"tagName":"p"}]},{"val":[{"type":"text","content":"Reinforces Nociscan’s non-invasive advantage with real-world clinical validation compared to anesthetic discography, a spinal injection procedure","length":145,"tagName":"p"}]},{"val":[{"type":"text","content":"Supports scalable growth strategy while building data assets critical to payer and provider adoption","length":100,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":309,"olType":false},{"type":"text","content":"BROOMFIELD, Colo., Feb. 03, 2026 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a commercial-stage healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, announced today it has established an agreement with Source Healthcare, a state-of-the-art orthopedic and regenerative health clinic in Los Angeles to help address a key gap in addressing low back pain.","length":535,"tagName":"p"},{"type":"text","content":"The agreement aligns with Aclarion’s expansion strategy by bringing Nociscan to Source Healthcare and the multidisciplinary team led by interventional pain management specialist, Timothy T. Davis, MD. Moreover, the growing evidence base for Nociscan will be strengthened by adding a high-volume clinical practice where real-world evidence comparing Nociscan and anesthetic discography will be generated. An anesthetic discogram is a diagnostic spinal injection procedure used to identify specific spinal disc(s) causing chronic pain. Nociscan is a non-invasive alternative that objectively measures pain and structural integrity biomarkers in spinal discs through an...